EyePoint director receives 40,000 stock options
EyePoint, Inc. director Reginald J. Sanders reported a grant of stock options.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
EyePoint, Inc. director Reginald J. Sanders reported a grant of stock options. On January 2, 2026, he received 40,000 stock options with an exercise price of $17.48 per share. These options become exercisable on January 2, 2027 and expire on January 2, 2036, and each option corresponds to one share of common stock. Following this grant, Sanders beneficially owns 40,000 derivative securities, held in direct ownership.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) | 40,000 | $0.00 | $0.00 |
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did EyePoint (EYPT) report for Reginald J. Sanders?
What is the exercise price of the new EyePoint (EYPT) stock options?
When do the newly granted EyePoint (EYPT) stock options become exercisable?
When do Reginald J. Sanders’ EyePoint (EYPT) stock options expire?
How many derivative securities does Reginald J. Sanders own after this EyePoint (EYPT) transaction?
Is Reginald J. Sanders’ EyePoint (EYPT) ownership direct or indirect?
AI-generated analysis. How Rhea-AI works. Not financial advice.